Resources
The GLRCE’s catalog of resources facilitate communication during an emergency in order to streamline the response. The GLRCE is also committed to educating the public and the first responders to infectious disease emergencies. Together, these efforts will provide technology, reagents and laboratory infrastructure to the biodefense community, will deliver education in classroom and laboratory settings, generate emergency response strategies and train emergency response providers for the region and nation.
Research resources
National Screening Laboratory for the RCEs (NSRB)
The National Screening Laboratory for the RCEs, located at Harvard University, supports research directed towards the identification of small molecules that enhance our understanding of the basic biology of pathogens relevant to biodefense or emerging infectious disease, and development of new therapeutic agents against these NIAID Priority Pathogens. The NSRB provides access to small molecule collections and assistance in conducting and interpreting high-throughput screens for all investigators conducting research relevant to these aims. The NSRB also has medicinal chemistry capability to advance promising screening hits toward pharmaceutical development.
NSRB made available multiple Pipeline Pilot-based protocols that will be of use to screeners in analyzing their data. A brief description of these tools and how to access them from remote locations is available at the NSRB website (under General Data Analysis at ( http://nsrb.med.harvard.edu/dataanalysis.html ). These protocols were developed based on questions and requests that received from screeners.
NIAID and NIH have requested more detailed policies and better compliance with respect to sharing of grant-generated data and citation of grant support. Therefore the User agreement and Data Sharing policy have recently been updated.
2009 Data Sharing Policy overview (PDF)
NSRB User Agreement form (PDF) (Word)
NIH Public Access Policy in Brief
The NIH Public Access Policy ensures that the public has access to the published results of NIH funded research. It requires scientists to submit journal articles that arise from NIH funds to the digital archive PubMed Central. The Policy requires that these articles be accessible to the public on PubMed Central to help advance science and improve human health.
The Law
The NIH Public Access Policy implements Division G, Title II, Section 218 of PL 110-161 (Consolidated Appropriations Act, 2008) which states:
SEC. 218. The Director of the National Institutes of Health shall require that all investigators funded by the NIH submit or have submitted for them to the National Library of Medicine's PubMed Central an electronic version of their final, peer-reviewed manuscripts upon acceptance for publication, to be made publicly available no later than 12 months after the official date of publication: Provided, That the NIH shall implement the public access policy in a manner consistent with copyright law.
NIH notice of January 11, 2008 regarding compliancy to Public Access Policy, updated on March 29, 2009.
Training Slides
- Public Access Training (PowerPoint - 706 KB)
- Tutorials for both PIs and non PIs
- Flowchart for the whole process (PDF)
